Skip to main content

ABBV: This Top Biotech Just Went On A Buying Spree

AbbVie stock is a buy following its recent merger & acquisition activity (Immunogen and Cerevel).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.